摘要
目的:观察依达拉奉注射液联合舒血宁注射液治疗急性脑梗死的临床疗效分析。方法:将108例急性脑梗死患者随机分为两组。治疗组以依达拉奉注射液30mg+0.9%氯化钠注射液100ml,舒血宁注射液20ml+0.9%氯化钠注射液250ml静脉滴注,1次/d。对照组以丹参注射液20ml+0.9%氯化钠注射液250ml静脉滴注,1次/d。两组患者均治疗14d为1个疗程,治疗1个疗程后观察疗效。结果:两组患者经治疗后,疗效比较,有效率相差11.9%,有效率明显提高,说明治疗组比对照组的治疗效果明显。结论:依达拉奉注射液联合舒血宁注射液治疗急性脑梗死两药合用,能起到协同作用。加强了对自由基的清除,保护了脑细胞、血管内皮细,扩张脑血管,明显改善了由于梗死导致的周围组织缺血情况,从而减轻了脑梗死所导致的一系列神经症状,对急性脑梗死有明显的治疗和保护作用。
Objective： To observe the clinical curative effect of edaravone injection and shuxuening injection in treating acute cerebral infarction. Methods： 108 cases of acute cerebral infarction patients were randomly divided into 2 groups. Treatment group were given edaravone injection 30 mg＋0.9% sodium chloride injection 100 ml, shuxuening injection 20ml＋0.9% sodium chloride injection 250 ml, 1 time/day. Control group were given Salvia miltiorrhiza injection 20 ml＋0.9% sodium chloride injection 250 ml, 1 time/day. Two groups of patients were treated for 1 course of 14 days, the treatment results were observed after 1 course. Results： Two groups of patients after treatment, in comparison, difference in efficiency was 11.9%, effective rate was better in the treatment group than the control group. Conclusion： Edaravone injection and shuxuening injection on acute cerebral infarction two-drug combination, can play a collaborative role, increase focus on free radical scavenging, protects brain cells, vascular endothelial thin, dilate cerebral blood vessels, significantly improve the surrounding tissue ischemia due to infarction, thus reducing a range of neurological symptoms are caused by cerebral infarction, evident in the treatment of acute cerebral infarction and protective effect.
出处
《中国当代医药》
2011年第30期63-64,共2页
China Modern Medicine
关键词
急性脑梗死
CT
依达拉奉注射液
舒血宁注射液
丹参注射液
Acute cerebral infarction
CT
Edavavone injection
Shuxuening injection
Miltiorrhiza injection
